Vitamina D y piel

Autores/as

  • Ana Lucía Molina
  • Ángela Londoño

DOI:

https://doi.org/10.29176/2590843X.235

Palabras clave:

vitamina D, neoplasias cutáneas, radiación ultravioleta

Resumen

La vitamina D es un nutriente esencial que puede obtenerse por exposición solar, suplementos o en la dieta. Históricamente, se ha considerado como fundamental en la homeostasis del calcio y el fósforo, pero actualmente se han encontrado múltiples y diferentes funciones en la regulación del crecimiento y proliferación celular, como inmunomodulador, como antioxidante, en el control del sistema renina-angiotensina-aldosterona y en la producción de insulina, entre otras. Sus efectos están regulados por factores endógenos y exógenos, y su deficiencia se ha asociado a diferentes enfermedades como cáncer, enfermedades autoinmunitarias, enfermedades cardiovasculares e infecciones.
El objetivo de este artículo fue hacer una revisión actualizada y completa sobre la vitamina D, sus efectos, sus funciones y las posibles complicaciones de su deficiencia. Se presenta esta revisión por ser un tema de actualidad, de gran controversia e importancia en el campo de la Dermatología.

Biografía del autor/a

Ana Lucía Molina

Médica, residente III de Dermatología, Facultad de Medicina, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, Colombia

Ángela Londoño

Médica dermatóloga y epidemióloga; docente, Facultad de Medicina, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, Colombia

Referencias bibliográficas

1. Dusso A, Brown A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-28.
2. Lehmann B, Meurer M. Vitamin D metabolism. Dermatol Ther. 2010;23:2-12.
3. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
4. Kochupillai N. The physiology of vitamin D: Current concepts. Indian J Med Res. 2008;127:256-62.
5. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: Physiology and biomarkers. Am J Clin Nutr. 2008;88:500S-6.
6. Norman A. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:491-9.
7. Holick M. Vitamin D: A D-Lightful health perspective. Nutr Rev. 2008;66:182-94.
8. Jurutka P, BartikJ, Whitfield G, Mathern D, Barthel T, Gurevich M, et al. D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res. 2007;22:2-10.
9. Holick M. The cutaneous photosynthesis of previtamin D3: A unique photoendocrine system. J Invest Dermatol. 1981;77:51-8.
10. Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Nutr Rev. 2008;66:S153-64.
11. Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006;50:640-6.
12. Holick M. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
13. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678-88.
14. Calvo M, Whiting S, Barton C. Vitamin D intake: A global perspective of current status. J Nutr. 2005;135:310-6.
15. Hanley D, Davison K. Vitamin D insufficiency in North America. J Nutr. 2005;135:332-7.
16. Ashwell M, Stone EM, Stolte H, Cashman KD, Macdonald H, Lanham-New S, et al. Fraser DUK Food Standards Agency Workshop Report: An investigation of the relative contributions of diet and sunlight to vitamin D status. 2010;104:603-11.
17. Vanchinathan V, Lim HW. A dermatologist’s perspective on vitamin D. Mayo Clin Proc. 2012 Apr;87(4):372-80.
18. Stechschulte S, Robert B, Kirsner S, Federman D. Vitamin D: Bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009;122:793-802.
19. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess. 2007;158:1-235.
20. Bacchetta J, Ranchin B, Dubourg L, Cochat P. Vitamin D revisited: A cornerstone of health? Arch Pediatr. 2010;13:115-20.
21. Nagpal S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662-87.
22. DeLuca HF. Overview of general physiologic, features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689-96
23. Lehmann B, Querings K, Reichrath J. Vitamin D and skin: New aspects for dermatology. Exp Dermatol. 2004;3:11-5.
24. Reichrath J, Perez A, Chen TC, Kerber A, Bahmer FA, Holick MF. The effectiveness of topical 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) application in the treatment of psoriasis: An immunohistological evaluation. Acta Derm Venereol. 1997;77:268-72.
25. Bikle D. Vitamin D and the skin. J Bone Miner Metab. 2010;28:117-30.
26. Lehmann B. Role of the vitamin D3 pathway in healthy and diseased skin facts, contradictions and hypotheses. Exp Dermatol. 2009;18:97-108.
27. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem. 2003;253:247-54.
28. Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65:106-13.
29. van Etten E, Decallone B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C. Analogs of 1a,25 dihydroxyvitamin D3 as pluripotent immunomodulators. J Cell Biochem. 2003;88:223-26.
30. Heine G, Anton K, Henz B M, Worm M. 1a,25-D hydroxyvitaminD3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol. 2002;32:3395-404.
31. Katayama I, Minatohara K, Yokozeki H, NishiokaK. Topical vitamin D3 downregulates IgE-mediated murine biphasic cutaneous reactions. Int Arch Allergy Immunol 1996;111:71-6.
32. Miller J, Gallo R. Vitamin D and innate immunity. Dermatol Ther. 2010;23:12-22.
33. Hong SP, Kim MJ, Jung MY, Jeo H, Goo J, Ahn SK, et al. Biopositive effects of low-dose UVB on epidermis: Coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 2008;128:2880-7.
34. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008;122:261-6.
35. Fabri M, Modlin RL. A vitamin for autophagy. Cell Host Microbe 2009;6:201-3.
36. Ho-Pham L, Nguyen N, Nguyen T, Bui P, Nguyen V, Nguyen T. Association between vitamin D insufficiency an tuberculosis in a Vietnamese population. BMC Infect Dis. 2010;25:306-10.
37. Hanada K, Sawamura D, Nakano H, Hashimoto I. Possible role of 1,25-dihydroxyvitamin D3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J Dermatol Sci. 1995;9:203-8.
38. Reichrath J. Vitamin D and the skin: An ancient friend, revisited. Exp Dermatol. 2007;16:618-25.
39. Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2008;25:539-43.
40. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: Preventing “D”ecline? Mol Aspects Med. 2008;29:415-22.
41. D’Holick MF, Siris ES, Binkley N. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90:3215-24.
42. Mullin GE, Turnbull L, Kines K. Vitamin D: A D-lightful health supplement. Nutr Clin Pract. 2009;24:642-4.
43. Holick M. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-73.
44. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28.
45. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805-6.
46. Morten KB, Schmedes B, Philipsen P, Thieden E, Wulf H. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol. 2010;130:546-53.
47. Chen T, Chimeh F, Lua Z, Mathieu J, Person K, Zhang A, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007;460:213-7.
48. Parra E. Human pigmentation variation: Evolution, genetic basis, and implications for public health. Am J Phys Anthropol. 2007;45:85-105.
49. Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: Implications on vitamin D levels. Intern Med J. 2009;39:256-8.
50. Wortsman J, Matsuoka J, Chen T, Lu Z, Holick M. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-3.
51. Alemzadeha R, Kichlerb J, Babara G, Calhouna M. Hypovitaminosis D in obese children and adolescents: Relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008;57:183-91.
52. Holick M. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61:638S-45S.
53. Matsuoka L, Wortsman J, Hanifan N, Holick M. Chronic sunscreen use decreases circulating concentrations of 5-hydroxyvitamin D. A preliminary study. Arch Dermatol. 1988;124:1802-4.
54. Querings K, Girndt M, Geisel J, George T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab. 2006;91:526-9.
55. Marks R, Foley P, Jolley D, Knight K, Harrison J, Thompson S. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol. 1995;131:415-21.
56. Reichrath J. Skin cancer prevention and UV-protection: How to avoid vitamin D-deficiency? Brit J Dermatol. 2009;161:60.
57. Hatun S, Islam O, Cizmecioglu F, Kara B, Babaoglu K, Berk F, Gökalp AS. Subclinical vitamin D deficiency is increased in adolescent girls who wear concealing clothing. J Nutr. 2005;135:218-2.
58. Grant W. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94:1867-75.
59. Holick M. Vitamin D and sunlight: Strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548-54.
60. Moan J, Porojnicu A, Robsahm T, Dahlback A, Juzeniene A, Tretli S, Grant W. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B. 2005;78:189-93.
61. Kampman E, Slattery M, Caan B, Potter J. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control. 2000;11:459-66.
62. Wactawski-Wende J, Kotchen J, Anderson G, Assaf A, Brunner R, O’Sullivan M, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-96.
63. Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007; 22:81-5.
64. Gupta D, Lammersfeld CA, Trukova K, Lis CG. Vitamin D and prostate cancer risk: A review of the epidemiological literature. Prostate Cancer Prostatic Dis. 2009;12:215-26.
65. John E, Schwartz G, Dreon M, Koo J. Vitamin D and breast cancer risk: The NHANES I epidemiologic follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev. 1999;8:399-406.
66. Kuper H, Yang L, Sandin S, Lof M, Adami H, Weiderpass E. Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev. 2009;18:2558-61.
67. Pérez-López F, Chedraui P, Haya J, Vitamin D acquisition and breast cancer risk. Reprod Sci. 2009;16:7-19.
68. Gandinia S, Raimondia S, Gnagnarellaa P, Dore´b J, Maisonneuvea P, Testoric A. Vitamin D and skin cancer: A meta-analysis. Eur J Cancer. 2009;45:634-41.
69. Nürnberg B, Gräber S, Gärtner B, Geisel J, Pföhler C, Schadendorf D, Tilgen W, Reichrath J. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res. 2009;29:3669-74.
70. Osborne J, Hutchinson J. Vitamin D and systemic cancer: Is this relevant to malignant melanoma? Br J Dermatol. 2002;147:197-213.
71. Kamen D, Cooper G, Bouali H, Shaftman S Hollis B, Gilkeson G. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5:114-7.
72. Holick M. The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med.2008;29:361-8.
73. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and aardiovascular mortality. Arch Intern Med. 2008;168:1340-9.
74. Wang T, Pencina M, Booth S, Jacques P, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-11.
75. Weinstock M, Moses A. Skin cancer meets vitamin D: The way forward for dermatology and public health. J Am Acad Dermatol. 2009;61:720-4.
76. Robert J, Lim W. Recommendations on photoprotection and vitamin D. Dermatol Ther. 2010;23:82-5.
77. Reichrath J. Protecting against adverse effects of sun protection. J Am Acad Dermatol. 2003;49:1204-6.

Cómo citar

1.
Molina AL, Londoño Ángela. Vitamina D y piel. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2012 [citado 28 de marzo de 2024];20(3):239-52. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/235

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2012-07-01

Cómo citar

1.
Molina AL, Londoño Ángela. Vitamina D y piel. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2012 [citado 28 de marzo de 2024];20(3):239-52. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/235

Número

Sección

Artículo de revisión
Crossref Cited-by logo